Humacyte, Inc. (HUMA) dividend history

HUMANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 2/30

$0.60+0.00 (+0.63%)

Close on Nov 12, 2026Market cap $165.40MP/E –Yield –

Dividends

No dividend per share appears in Humacyte's annual filings since fiscal 2019.

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is HUMA.

Revenue growth52.5% · median -1.9%

Gross margin-475.1% · median 34.1%

Operating margin-4602.9% · median -1342.3%

Net margin-3955.1% · median -1156.2%

Advertisement
300 × 250

See a number that looks wrong?